obviously a bad outcome for all involved today. it does say that the FDA has requested another trial and further explanation around the MOA, how does everyone view this? personally I feel the extra trial isn't altogether terrible as I'd imagine Mesoblast can gather the nessacerry data from another trial to apiece the FDA.
The big concern for me is that the FDA don't seem happy that Mesoblast has is accross the MOA, this doesn't seem like something they can fix in a few months, if they haven't got a full grasp of it in the years they've invested I'm not sure a few months extra is going to help.
obviously a bad outcome for all involved today. it does say that...
-
- There are more pages in this discussion • 333 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.010(1.01%) |
Mkt cap ! $1.141B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.01 | 94.3¢ | $8.618M | 8.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43508 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 34138 | 2 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |